Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

NCT01246206 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies

Interventions

DRUG: Tacrolimus and Thymoglobulin

Sponsor

Barbara Ann Karmanos Cancer Institute